Bothell-based Curevo Vaccine, a privately held clinical-stage biotechnology company dedicated to developing vaccines with ...

The Access to Advanced Health Institute (AAHI), a nonprofit biotech organization dedicated to developing vaccines and ...

The drugmaker announced it will buy three privately held vaccine makers in deals worth almost $4 billion combined.

It felt like being cut with a knife,” “It felt like electricity was flowing through my body,” “It was to the point of screaming even if a collar merely brushed against me.” These are expressions used ...

While vaccinations are often linked to babies and children, adults need them just as much, especially seniors whose immune ...

The drugmaker said it would spend up to $4 billion to acquire small companies exploring vaccines for shingles, Epstein-Barr ...

A new theory suggests many age-related diseases may actually start decades before symptoms appear. Researchers say early-life damage — from infections, injuries, or genetic mutations — can remain ...

The Big Pharma is paying up to $1.5 billion, split between an upfront fee and a milestone payment, to buy shingles vaccine ...

Glucagon-like peptide-1 receptor agonists, aka GLP-1s, are one of the best-known synthetic peptides and the active ingredient ...

Food and Drug Administration commissioner’s decisions have hurt staff morale and put his job in crosshairs ...

Researchers report that a new drug, bepirovirsen, could revolutionize hepatitis B treatment by making the virus undetectable ...